Tuesday, July 1, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Manufacturing

Manufacturing: CCI approves BSV acquisition by Mankind

Fiinews by Fiinews
October 3, 2024
in Manufacturing
Reading Time: 1 min read
A A
0
Mankind
0
SHARES
16
VIEWS
LinkedinShare on Twitter

0:00

BSV markets biological, biotech and pharmaceutical products

Competition Commission of India (CCI) has approved the acquisition of Bharat Serums and Vaccines Limited (BSV) by Mankind Pharma Ltd which develops, manufactures, and markets a diverse range of pharmaceutical finished dosage formulations (FDFs) across various acute and chronic therapeutic areas, as well as several consumer healthcare products such as condoms, emergency contraceptives, pregnancy tests, vitamins, minerals, nutrients, antacids and anti-acne preparations segments.

The proposed transaction involves the acquisition of 100% shareholding of BSV by Mankind, a public listed company which through its subsidiaries is also engaged in, inter alia, the manufacture and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediaries, and packaging products for pharmaceutical products.

BSV, along with its subsidiaries, is engaged in research, development, licensing, manufacturing, importing, exporting, marketing and distribution of: (a) FDFs and APIs; (b) biotech and biological formulations and/or API; (c) food and health supplements; (d) medical devices; and (e) ayurvedic medicines; in each case, in the therapeutic areas such as gynaecology, in-vitro fertilisation, critical care and/or emergency medicines for human use.

In India, the activities of BSV (including its wholly owned Indian subsidiary, BSV Pharma Private Limited, which is in the process of merging with BSV) are limited to developing, manufacturing, and marketing a range of biological, biotech, and pharmaceutical products in the therapeutic areas of women’s health, critical care, IUI-IVF, and emergency medicine, CCI said on 2 Oct 2024. Fiinews.com

Tags: CCI
ShareTweetShare

Related Posts

Ericsson
Manufacturing

Manufacturing: India benefits form global partners

by Fiinews
July 1, 2025
0
15

Ericsson, Apple, Google and Qualcomm contribute beyond investments Minister of Communications Jyotiraditya M. Scindia has underlined the transformative impact of...

Greenzo Energy
Manufacturing

Manufacturing: Greenzo to invest in electrolyser

by Fiinews
July 1, 2025
0
14

Agarwal committed to green hydrogen ecosystem, New Delhi's Greenzo Energy Ltd remains committed to delivering world-class indigenous solutions that put...

RRP S4E

Manufacturing: India to get Bulgarian technology

July 1, 2025
15
Ohmium

Manufacturing: Partnership for hydrogen solutions

June 29, 2025
13
Sekisui

Manufacturing: Sekisui expands capacity in Pune

June 26, 2025
13
EVIndia

Manufacturing: MHI launches EV SPMEPCI

June 25, 2025
13
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Tech: Military-grade integrity for digital space
  • Tech: SatSure-Dhruva Space to work on value chain
  • Tech: WaveX invites startups to create AI-solution
  • Export: Govt to facilitate easy trade environment
  • Tender: India plans 5,000 km of waterways

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.